Drug Solutions Podcast: Dosage Forms: Roundtable on Oral Solid Dosage Trends
In this podcast episode, we discuss trends in dosage forms, specifically oral solid dosage, as viewed by five industry experts who recently exhibited at CPHI Milan.
Dosage forms, in particular oral solid dose, continue to evolve as new technologies enter the market, and as customer tastes and demands change. In this episode of the Drug Solutions podcast, Patrick Lavery, editor for Pharmaceutical Technology®, Pharmaceutical Technology EuropeTM, and BioPharm International®, surveys attendees from the recent CPHI Milan gathering about how fast the market is expanding, how it's evolved in recent years and even decades, and what drugs are most conducive to OSD formulations.
About the Speakers
Michelle Logan is vice president, drug product division, Thermo Fisher Scientific. Her CPHI interview can be viewed in full here.
Vinod Tuliani is head of global pharmaceutical sciences, Roquette. His CPHI interview can be viewed in full here.
Camille Dumont, PhD, is manager of customer applications, Lonza. Her CPHI interview can be viewed in full here.
Dr. Uwe Hanenberg is head of product implementation, oral solid dose, Recipharm. His CPHI interview can be viewed in full here.
Dr. Ali Rajabi-Siahboomi is vice president and chief innovation officer, Colorcon. His CPHI interview can be viewed in full here.
About the Drug Solutions Podcast
Pharmaceutical Technology presents the Drug Solutions podcast, where the editors will chat with industry experts from across the pharmaceutical and biopharmaceutical supply chain. Join us as experts share insights into your biggest questions—from the technologies, to strategies, to regulations related to the development and manufacture of drug products.
Listen to this podcast on SoundCloud, Spotify, Google Podcasts, or Apple Podcasts.
